[Double-blind cross-over study of imecromone and placebo in the treatment of dyspeptic syndrome].
作者信息
Coccia G, Michetti P, Rossetti S, Dodero M
出版信息
Minerva Dietol Gastroenterol. 1985 Apr-Jun;31(2):293-8.
PMID:3897908
Abstract
摘要
相似文献
1
[Double-blind cross-over study of imecromone and placebo in the treatment of dyspeptic syndrome].[茴三硫与安慰剂治疗消化不良综合征的双盲交叉研究]
Minerva Dietol Gastroenterol. 1985 Apr-Jun;31(2):293-8.
2
3
[Hymecromone in the treatment of symptoms following surgery of the bile ducts].[羟甲香豆素治疗胆管手术后症状]
Recenti Prog Med. 1988 May;79(5):198-202.
4
5
Hymecromone in the treatment of motor disorders of the bile ducts: a multicenter, double-blind, placebo-controlled clinical study.
Drugs Exp Clin Res. 2001;27(5-6):223-31.
6
Effect of pirenzepine in the treatment of non-ulcer dyspepsia. A double-blind study.哌仑西平治疗非溃疡性消化不良的效果。一项双盲研究。
Scand J Gastroenterol Suppl. 1982;72:251-4.
7
[Hymecromone in postoperative therapy after choledochotomy].
MMW Munch Med Wochenschr. 1983 Apr 22;125(16):345-7.
8
[Treatment of dyspeptic disorders, lithiasis and biliary dyskinesia with ursodeoxycholic acid. Analysis of a controlled multicenter study].[用熊去氧胆酸治疗消化不良症、结石症和胆道运动障碍。一项对照多中心研究的分析]
Schweiz Med Wochenschr. 1980 May 31;110(22):879-80.
9
Pirenzepine in non-ulcer dyspepsia. A double-blind, placebo controlled trial.哌仑西平治疗非溃疡性消化不良。一项双盲、安慰剂对照试验。
Scand J Gastroenterol Suppl. 1982;72:247-50.
10
[Hymecromone in diseases of the bile ducts].[利胆酚在胆管疾病中的应用]
MMW Munch Med Wochenschr. 1978 May 26;120(21):741-2.
引用本文的文献
1
Modulation of hyaluronan signaling as a therapeutic target in human disease.透明质酸信号转导的调控作为人类疾病的治疗靶点。
Pharmacol Ther. 2022 Apr;232:107993. doi: 10.1016/j.pharmthera.2021.107993. Epub 2021 Sep 26.
Zotero 插件